Scholars have designed a variety of nanodelivery systems to enhance the blood oxygen content of tumor sites, including direct oxygen delivery (by hemoglobin or perfluorocarbons NPs), catalytic oxygen production strategies (catalase oxygen-producing nanodelivery system), and so on. This evidence concerns the gene CAT and neoplasm.